$12750 | SAVE $2,250 | Single User
$17850 | SAVE $3,150 | Site License
$22950 | SAVE $4,050 | Enterprise License

Drug Discovery Outsourcing Global Market – Forecast To 2022
[Report Updated: 13-01-2016]

Published by IQ4I: 13 Jan 2016 | 111548 | In Stock
Related Topics: Bioscience , Drug Discovery

Introduction

Over the last two decades, the Pharmaceutical/Biotech industry has undergone radical changes. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards biologics have seen a surge in the externalization and outsourcing activities. As the industry is looking for new sources of discovery and innovation with limited resources, there is a growing preference to move towards externalization and willingness to embrace the concept of outsourcing, IQ4I estimates that ~15% of the pharmaceutical/biotech R&D spending goes into drug discovery.

Almost all the major Pharmaceutical/biotech companies are considering outsourcing as a core strategy to fill their discovery pipelines. Outsourcing companies that have precise capabilities through greater flexibility are the preferred ones. Now-a-days, the big pharma relies more on CRO’s for drug discovery capabilities to stock up their pipelines

The global pharmaceutical outsourcing market was estimated to be $XX billion in 2015 and of that a little less than fifty percent accounted for CRO’s. IQ4I estimates that the global drug discovery based services to be $XX billion in 2015 and rest accounts for biology-related service and clinical services. Current R&D outsourcing penetration is estimated to be ~ X percent of the global pharmaceutical and biotech industry spending but poised to grow at CAGR of X% percent in the coming years.

This report provides comprehensive insights on the global drug discovery outsourcing market. The report covers all segments, global trends and emerging strategies of the outsourcing market related to drug discovery. Major Drug Discovery Outsourcing (DDO) players included in the report are Evotec, Charles River Laboratories (CRL), Pharmaceutical Product Development (PPD), WuxiApptec, ChemPartner, Syngene, Aurigene, Jubilant Biosys, Advinus, GVK Biosciences, TCG Lifesciences and AMRI.

This report caters to the need of Contract research organizations, Pharmaceutical/Biotech companies, Academic institutes, Individual researchers, Investors, Service providers and other associated stake holders to identify and analyze the potential of the DDO market. The report also provides insights on customer base, number of deals between CRO’s and Pharmaceutical /biotech firms, global FTE rates, employee strength & number of companies, revenue per employee of major players, therapeutic area gap analysis and successful research collaboration outcomes of selected CRO’s and Sponsors, which are likely to have an impact on the DDO market in the foreseeable future.

This report covers in-depth analysis of major players by therapeutic area of focus, capabilities, geographic presence, business models, financials, collaborations, acquisitions, various marketing strategies adopted along with insightful analysis on conferences, clusters and match making websites.

Table of Contents
for Drug Discovery Outsourcing Global Market – Forecast To 2022 [Report Updated: 13-01-2016]

  • 1 INTRODUCTION

    2 MARKET ANALYSIS

    2.1 RESEARCH METHODOLOGY

    2.2 FORECASTING MODEL

    2.3 MARKET DYNAMICS

    2.4 MARKET SIZING

    2.5 EMERGING TRENDS & STRATEGIES

    3 BUSINESS OVERVIEW

    3.1 BUSINESS MODELS

    3.2 BUSINESS EVOLUTION

    3.3 CERTIFICATIONS

    3.4 DD INDICATORS

    3.5 PHARMA R&D EXP & INTENSITY

    4 COMPETITOR ANALYSIS

    4.1 THERAPEUTIC AREA MATRIX

    4.2 GLOBAL FTE RATES

    4.3 REGIONAL REVENUES VS FTE

    4.4 KEYPLAYERS (REVENUE PER EMPLOYEE, CUSTOMERS, DEALS & TA PIE CHART, COLLABORATION OUTCOMES)

    5 LEADING PLAYERS

    5.1 OVERVIEW

    5.2 CAPABILITIES

    5.3 THERAPEUTIC AREA

    5.4 BUSINESS MODELS

    5.5 COLLABORATIONS

    5.6 ACQUISITIONS

    6 MARKETING STRATEGIES

    6.1 CONFERENCES

    6.1.1 CONFERENCES -2014, 2015, 2016

    6.1.2 CONFERENCE ANALYSIS- 2014-15

    6.2 MATCH MAKING WEBSITES

    6.3 VIRTUAL PHARMACEUTICALS

    6.4 ONLINE RPFS

    6.5 NETWORKING WEBSITES

    6.6 CLUSTERS

    6.7 OTHER MARKETING STRATEGIES

    6.7.1 WEBSITE RANKINGS, LINKEDIN FOLLOWERS, GOOGLE SEARCH VOLUMES

Additional Details

Publisher

IQ4I

Publisher Information

IQ4I is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.



We are a team of highly qualified market researchers and consultants, committed to help clients make strategic decisions by providing relevant and firmly reliable data support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports and Business Development & licensing services and provide support in hiring with best talents.

Reference

111548 | Drug Discovery Outsourcing Global Market Report 13012016

Number of Pages

182

Report Format

PDF

IQ4I Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Orphan Drug Commercial Models: Sustaining the rare disease business
IntroductionChoosing the right commercial model for orphan drug successThe societal and commercial a...
01 May 2016 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Pay-for-Performance and Drug Pricing: Impact and Response of Pharma [2016]
IntroductionThe pay for performance agenda gathers pace as US payers rebel the cost of drugs.Pharma ...
01 Mar 2016 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Innovations in Drug Pricing and Reimbursement (2016)
IntroductionIs the drug pricing bubble about to burst?Drug costs are becoming unaffordable and draco...
01 Feb 2016 by FirstWord Pharma USD $1,866 (normally
USD $2,195)
More Info
SAVE 15% today! Drug Delivery - Innovations, trends, and their impact on pharma
IntroductionWhy you need Drug Delivery - Innovations, trends, and their impact on pharmaRevolutionar...
01 Nov 2015 by FirstWord Pharma USD $1,866 (normally
USD $2,195)
More Info
SAVE 15% today! Physician Views: Which companies excel in diabetes drug marketing and why?
Scope With both the insulin and non-insulin segments of the diabetes market expected to become more ...
01 May 2015 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Trends and Innovations in Drug Pricing
IntroductionFirstWord’s Trends and Innovations in Drug Pricing report dissects international trends ...
01 Jan 2015 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Orphan Drug Market Access: Payer Insights on the Present and Future
IntroductionOrphan Drug Market Access: Payer Insights on the Present and Future is a report that exa...
14 Oct 2014 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views: With drug developers on the brink of Phase III for NASH, how large is the actual market opportunity?
Scope While no drugs are approved for non-alcoholic steatohepatitis (NASH), at least eight agents ha...
04 Aug 2014 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views: As Tecfidera approaches a critical juncture in Europe, how are neurologist perceptions towards Biogen Idec's MS drug shaping up?
ScopeSales of Biogen Idec’s multiple sclerosis therapy Tecfidera may continue to exceed initial expe...
01 Nov 2013 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views: Recent developments in US diabetes market – impact of safety concerns & emergence of SGLT-2 drug class
ScopeWith the diabetes market an important therapeutic area for a host of pharmaceutical manufacture...
01 Jun 2013 by FirstWord Pharma USD $591 (normally
USD $695)
More Info

This report is published by IQ4I

IQ4I is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.

We are a team of highly qualified market researchers and consultants, committed to help clients make strategic decisions by providing relevant and firmly reliable data support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports and Business Development & licensing services and provide support in hiring with best talents.

Download Free Report Summary PDF

Drug Discovery Outsourcing Global Market  – Forecast To 2022 [Report Updated: 13-01-2016] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...